価格表

在庫・価格 : 2024年05月06日 02時34分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Sclerostin, His-tagged, Human, Recombinant <SOST>
データシート
1406-ST-025 RSDアールアンドディー システムス
R&D Systems, Inc.
25 μg ¥86,000
(未発注)
追加

在庫・価格 : 2024年05月06日 02時34分 現在

Sclerostin, His-tagged, Human, Recombinant <SOST>

  • 商品コード:1406-ST-025
  • メーカー:RSD
  • 包装:25μg
  • 価格: ¥86,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Winkler DG et al. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J. Biol. Chem. 2005 Jan;280(4):2498-502
Winkler DG et al
2005/01/01
Species: Mouse, Application: Bioassay, Whole Cells PubMed
2 Vincent C et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J. Bone Miner. Res. 2009 Aug;24(8):1434-49
Vincent C et al
2009/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
3 Seckinger A et al. Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. Oncogene 2009 Nov;28(44):3866-79
Seckinger A et al
2009/01/01
Application: proliferation assay, Sample Type: Whole Cells PubMed
4 J辰ger A et al. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. J. Periodont. Res. 2010 Apr;45(2):246-54
J辰ger A et al
2010/01/01
Application: Western Blot Control PubMed
5 Appel H et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2009 Nov;60(11):3257-62
Appel H et al
2009/01/01
Application: ELISA development, Sample Type: Serum PubMed
6 Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
Wilson TR et al
2012/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
7 Kogawa M et al. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. J. Bone Miner. Res. 2013 Dec;28(12):2436-48
Kogawa M et al
2013/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
8 Shu R et al. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. PLoS ONE 2017;12(1):e0167312
Shu R et al
2017/01/01
Application: Bioassay, Sample Type: Whole Cells PubMed
  • No.: 1
  • 文献情報:
    Winkler DG et al. Sclerostin inhibition of Wnt-3a-induced C3H10T1/2 cell differentiation is indirect and mediated by bone morphogenetic proteins. J. Biol. Chem. 2005 Jan;280(4):2498-502
    Winkler DG et al
    2005/01/01
  • 備考:
    Species: Mouse, Application: Bioassay, Whole Cells
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Vincent C et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J. Bone Miner. Res. 2009 Aug;24(8):1434-49
    Vincent C et al
    2009/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Seckinger A et al. Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis. Oncogene 2009 Nov;28(44):3866-79
    Seckinger A et al
    2009/01/01
  • 備考:
    Application: proliferation assay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    J辰ger A et al. Localization of SOST/sclerostin in cementocytes in vivo and in mineralizing periodontal ligament cells in vitro. J. Periodont. Res. 2010 Apr;45(2):246-54
    J辰ger A et al
    2010/01/01
  • 備考:
    Application: Western Blot Control
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Appel H et al. Altered skeletal expression of sclerostin and its link to radiographic progression in ankylosing spondylitis. Arthritis Rheum. 2009 Nov;60(11):3257-62
    Appel H et al
    2009/01/01
  • 備考:
    Application: ELISA development, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Wilson TR et al. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012 Jul;487(7408):505-9
    Wilson TR et al
    2012/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Kogawa M et al. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2. J. Bone Miner. Res. 2013 Dec;28(12):2436-48
    Kogawa M et al
    2013/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Shu R et al. Sclerostin Promotes Bone Remodeling in the Process of Tooth Movement. PLoS ONE 2017;12(1):e0167312
    Shu R et al
    2017/01/01
  • 備考:
    Application: Bioassay, Sample Type: Whole Cells
  • 参照:
    PubMed